The IL-1 pathway is hyperactive in Hidradenitis suppurativa and contributes to skin infiltration and destruction

The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls

JAMA Dermatol.

Ring HC, Thorsen J, Saunte DM, Lilje B, Bay L, Riis PT, Larsen N, Andersen LO, Nielsen HV, Miller IM, Bjarnsholt T, Fuursted K, Jemec GB

doi: 10.1001/

COMMENTED

Acne

Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers

J Eur Acad Dermatol Venereol.

Vossen ARJV, van der Zee HH, Davelaar N, Mus AMC, van Doorn MBA, Prens EP

doi: 10.1111/jdv.15354.

Acne

Clinical Response Rates, Placebo Response Rates and Significantly Associated Covariates Are Dependent Upon Choice of Outcome Measure in Hidradenitis Suppurativa: A Post-Hoc Analysis of PIONEER 1 and 2 Individual Patient Data

J Am Acad Dermatol.

Frew JW, Jiang CS, Singh N, Grand D, Navrazhina K, Vaughan R, Krueger JG

doi: 10.1016/j.jaad.2019.12.044.

COMMENTED

Acne

North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: Diagnosis, Evaluation, and the use of Complementary and Procedural Management

J Am Acad Dermatol.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brasasard A, Burkhart C, Crowell K, Eisen D, Gottlieb A, Hamzavi I, Hazen P, Jaleel T, Kimball A, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y

doi: 10.1016/j.jaad.2019.02.067.

AcneFurther Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance

J Invest Dermatol.

Frew JW, Marzano AV, Wolk K, Join-Lambert O, Alavi A, Lowes MA, Piguet V

doi: 10.1016/j.jid.2020.06.019.

Acne

Real-world effectiveness of adalimumab in patients with moderate to severe hidradenitis suppurativa: The 1-year SOLACE study

J Eur Acad Dermatol Venereol

Gulliver W, Alavi A, Wiseman MC, Gooderham MJ, Rao J, Alam MS, Papp KA, Desjardins O, Jean C

doi: 10.1111/jdv.17598

Gout

The role of IL-1 in gout: from bench to bedside

Rheumatology (Oxford).

So A, Dumusc A, Nasi S

doi: 10.1093/

Acne

Hidradenitis Suppurativa Odor and Drainage Scale: A Novel Method for Evaluating Odor and Drainage in Patients with Hidradenitis Suppurativa

Br J Dermatol

Machado MO, Lu JD, Brar R, Kirby J, Garg A, Lowes M, Piguet V, Alavi A

doi: 10.1111/bjd.19686

Acne

Evidence for a "window of opportunity" in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicenter cohort study

Br J Dermatol.

Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K

doi: 10.1111/bjd.18983.

Related content

The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls

Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers

Clinical Response Rates, Placebo Response Rates and Significantly Associated Covariates Are Dependent Upon Choice of Outcome Measure in Hidradenitis Suppurativa: A Post-Hoc Analysis of PIONEER 1 and 2 Individual Patient Data

North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: Diagnosis, Evaluation, and the use of Complementary and Procedural Management

A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance

Real-world effectiveness of adalimumab in patients with moderate to severe hidradenitis suppurativa: The 1-year SOLACE study

The role of IL-1 in gout: from bench to bedside

Hidradenitis Suppurativa Odor and Drainage Scale: A Novel Method for Evaluating Odor and Drainage in Patients with Hidradenitis Suppurativa

Evidence for a "window of opportunity" in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicenter cohort study